[Federal Register Volume 65, Number 62 (Thursday, March 30, 2000)]
[Notices]
[Page 16964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-7874]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 16, 1999, and published in the Federal 
Register on December 28, 1999 (64 FR 248), Medeva Pharmaceuticals CA, 
Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724).....................  II
Diphenoxylate (9170).......................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished dosage forms for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Medeva Pharmaceuticals CA, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Medeva 
Pharmaceuticals CA, Inc. on a regular basis to ensure that the 
company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, 
the Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: March 23, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-7874 Filed 3-29-00; 8:45 am]
BILLING CODE 4410-09-M